CODX Stock Analysis: Buy, Sell, or Hold?
CODX - Co-Diagnostics, Inc. Common Stock
$1.21
0.06 (5.22%)
▲
5d:
-13.57%
30d:
-45.25%
90d:
-67.39%
HOLD
MODERATE Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When CODX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CODX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CODX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CODX is currently trading at $1.21, which is considered oversold relative to its 30-day fair value range of $1.33 to $2.28.
Technical Outlook: Technically, CODX is showing sideways momentum. Immediate support is located at $0.94, while resistance sits at $1.57. The stock is showing strong short-term momentum, up 5.2% recently.
Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $4.00 (+230.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CODX is showing sideways momentum. Immediate support is located at $0.94, while resistance sits at $1.57. The stock is showing strong short-term momentum, up 5.2% recently.
Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $4.00 (+230.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.33 -
$2.28
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (58/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.2%)
- BULLISH: Trading 230.6% below Wall St target ($4.00)
- NEUTRAL: Bottoming setup forming (58/100) — watch for confirmation
- CAUTION: 5-day price weakness (-13.6%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$1.33 -
$2.28
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.94
Resistance Level
$1.58
Current Trend
Sideways
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.46
Wall Street Target
$4.00
(+230.6%)
Revenue Growth (YoY)
2.0%
Earnings Growth (YoY)
30.8%
Share & Embed Analysis
Last updated: August 22, 2026 8:25 PM ET
Data refreshes hourly during market hours. Next update: 9:25 PM
Data refreshes hourly during market hours. Next update: 9:25 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CODX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 53 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 48 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 31 SELL |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$119 | 37 SELL |
